We are a research group at the University of Sydney. Our research covers a diverse range of fields within medicinal chemistry & drug discovery @Sydney_Uni.
Excellent flash talk given by Andrew Montgomery today on the optimised synthesis of the radiolabeling precursor and analytical standard of [18F]-Florzolotau. #MCCB2025#RACI
The #MCCB2025 conference in Darwin kicks off in style, with @alessiociulli delivering an amazing talk on dual ligase targeting molecular glues, and their new bromocatch tag
(Talk so good it blew the power out all across Darwin for a minute 😂)
Dr Ludovica Monti @LudovicaMonti@ChemistryUoM delivered a keynote lecture on her recent work the use of genomics to identify novel drug targets in neglected tropical diseases at the Infectious Disease session of the @RACInational#MCCB2025
A great short talk by Isabel Barter today at RACI MCCB 2025 on 'Cyclic peptide natural products dysregulate the proteome of Mycobacterium tuberculosis.'
#MCCB2025
An incredible performance and Welcome to Country by the Youth Mill Performing Arts Company, paying respect to the land and its Traditional Custodians at today’s RACI MCCB Conference.
#MCCB2025
🔔Voting for the DDI Research Image Contest 2024 - People's Choice award closes in two days! 📲 https://t.co/DxjUCKDtS1
This year fantastic snapshots from DDI members' labs have revealed the breadth and beauty of research being conducted @Sydney_Uni 🤩 Congrats to our nominees!
Congratulations to our PhD student Kris and all contributors on their new review article: "Enhancing CNS mitophagy: drug development and disease-relevant models". #Mitophagy
https://t.co/SwPXDXhMLQ
Huge Congrats to our PhD Students, Bill, Nick and Jack on their publication - "Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece".
🧩Fragment Based Drug Discovery is an exciting alternative method to develop new central nervous system active drugs.
DDI researchers and co-authors explore recent compelling examples of FBDD and its utility.
Read the review here 🔗 https://t.co/cZXvXNsDu8
Celebrating Alison’s 8 year tenure in the Kassiou Group before she jets off to London!
You have had a huge impact on the group, thankyou for all your work and good luck!
🧩Fragment Based Drug Discovery is an exciting alternative method to develop new central nervous system active drugs.
DDI researchers and co-authors explore recent compelling examples of FBDD and its utility.
Read the review here 🔗 https://t.co/cZXvXNsDu8